ORLANDO, Fla., April 1, 2008 /PRNewswire/ -- Valensa International introduced Crannose(TM) Extra Strength Women's Health Formula at this year's Natural Products Expo West Conference. This patent-pending supplement, manufactured using novel CIT technology, combines the historically known benefits of cranberry with D-mannose, a naturally occurring, non-caloric, simple sugar, extracted from the Larch tree. The product is available in bulk, 2-piece capsules, as a beverage pre-mix or beverage sachet formula.
According to Dr. Rudi E. Moerck, President of Valensa, there is a viable and growing market for a natural promoter of urinary tract health that can affect the conditions that lead to urinary tract infections (UTIs). "Antibiotics are the standard drug-based treatment for UTIs, but they often eliminate a woman's 'good' vaginal bacteria in the course of treating the targeted infection. This situation often leads to painful secondary fungal infections like Candida that can themselves require drug treatment. The increased use of antibiotics generally has contributed to antimicrobial resistance, a growing public health concern," he added.
Dual action targets urinary tract health
During UTIs, E. coli bacteria gain a foothold by adhering to the bladder wall and/or urethra, causing infection. Crannose(TM) Extra Strength creates an environment in the bladder that helps prevent bacteria from gaining that foothold. Supplementation with Crannose(TM) Extra Strength helps to acidify the urine, while its anti-adhesion properties naturally prevent bacteria from attaching to the urinary tract lining. It provides an ideal competitive receptor site for the bacteria, creating a "path of least resistance" for it to be excreted quickly and harmlessly.
Crannose(TM) Extra Strength is very slowly metabolized in the body, so
that when ingested, it travels directly to the bloodstream from the upper
GI tract, and is filtered through the kidneys to the bladder f
'/>"/>
| SOURCE Valensa International Copyright©2008 PR Newswire. All rights reserved |